The AHA Guidelines and Scientific Statements Handbook

Index

Valsartan 64, 68, 209, 227
Valve 296, 308, 310–1
aortic 297–8, 300–1, 310–1
bicuspid 302
calcifi cation 297–9
cardiac, repair 294
disease 294–5
gradients 296
mechanical heart 246–7
mitral 281, 304, 306–8, 311
morphology 299, 302–4
native 309–10, 315, 317–8, 328
332 334 322–23, 326, 330
nonpliable calcifi ed 304
prosthetic 309–10, 315, 329, 313–4, 319, 322–8, 330
repair 304
replacement 92, 293, 297–8, 300–1
resection 315
surgery 306, 308–9, 322
tricuspid 308
Valvotomy
aortic balloon 298
percutaneous mitral balloon 302–4
Valvular heart disease 293–311
Valvulopathy 294
Vancomycin 317–9, 318–25, 327–8, 335
Varapamil 204
Vardenafi l 33
Vasculitis 344–5
Vasculopathy, allograft 145
Vasodilation 162
Vasopressin 69, 75
Vegetation 313–4, 316, 326, 330
Vein
autogenous 180–1, 185
iliac 345
pulmonary 253–4
Venography 345
Ventricular
arrhythmia. See VA
fi brillation. See VF
septal rupture. See VSR
tachyarrhythmia. See VT
Ventriculography 39
contract 83
left 13
radionuclide 225

Verapamil 17, 33, 64–5, 75, 204, 208–10, 245, 251, 258–61,

264–5, 267–8, 276, 289, 291

Verapamil/diltiazem 259

Very low density lipoprotein 187

VF 72, 74, 275, 278, 280, 283–5, 289

Vitamin 216, 220, 246–7, 249, 252

VSR 46, 53, 55, 57, 60–1, 64, 66, 69, 71–3, 75, 78, 81,

83

VT 256–9, 261, 268, 275–9, 282–3, 285–6, 288–9

ablation 275, 277

catecholaminergic 273

idiopathic 277, 287

monomorphic 275, 280–2, 288

non-sustained spontaneous 285

polymorphic 277, 283

recurrent 276, 281, 290

refractory 288

polymorphic 73

septal 289

stable 280–1, 286

storm 277

sustained 292–5 275–6, 280, 282, 284–5, 288–9

symptomatic 288

unresponsive 279

unstable 285, 289

Warfarin 80, 84, 86, 110, 114, 137, 140, 175, 186, 234,

248–9, 254, 305, 310–1

WAVE trial 186

Weight 202–4, 212

management 25, 43–4, 94, 110, 113, 216

Whipple disease 241

WISE Study 221

Wolff–Parkinson–White syndrome 263, 274–5

Women 13, 24, 26, 37, 44–5, 141–2, 144, 188, 192–4, 199,

203, 205–6, 209–10, 214–22, 247, 337–9, 342

CVD prevention 215–21

pregnancy 211–2, 268–9, 289

WomenHeart 222

Working Group on Myocardial and Pericardial Diseases

242

X-linked DCM 241

Ximelagatran 253–4

Z-disc protein-encoding genes 240

ZASP 240